Loading...
NPI 1982891941 · Brooklyn, NY · Urology Physician
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Himansh Khanna is a urology physician provider located in Brooklyn, New York. This profile covers 30 Medicare and 4 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Individual |
| Organization | Himansh Khanna |
| Address | 540 5th Ave |
| City | Brooklyn |
| State | NY |
| ZIP | 11215 |
| Taxonomy | Urology Physician |
| NPI Enumerated | October 3, 2007 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicare | $281.9K |
| Medicaid | $7.1K |
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
30 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 51728 | In this procedure, the provider performs a complex cystometrogram along with voiding pressure studies to diagnose certain urinary disorders like an overactive bladder, stress incontinence, or urinary… | 120 | $350 | $41.7K |
| 51792 | This procedure measures the electrical activity in the anal or urethral sphincter muscles. | 120 | $260 | $31K |
| 93975 | The provider performs a complete study of the abdominal, pelvic, scrotal, and or retroperitoneal organs using duplex ultrasound. He performs the procedure to examine the vascular supply to the organs… | 100 | $260 | $26.4K |
| 93976 | The provider performs a duplex scan of a single organ or a limited area of the abdominal, pelvic, scrotal, or retroperitoneal organs. He performs the procedure to examine the vascular supply to the… | 170 | $140 | $23.4K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 250 | $80 | $19.7K |
| 76856 | A pelvic ultrasound is a noninvasive procedure used to assess body parts such as the bladder, ovaries, uterus, cervix, and fallopian tubes in females and the bladder, prostate gland, and seminal… | 140 | $100 | $13.6K |
| 88120 | The lab analyst performs a technical lab test on a urinary tract specimen using in situ hybridization and three to five molecular probes for manual morphometric analysis, looking at the number and… | 250 | $50 | $12.5K |
| 88342 | The lab analyst applies an initial single antibody stain on a slide or slides prepared from a single patient specimen, such as tumor tissue. Then a qualified provider, typically a pathologist,… | 400 | $30 | $12.1K |
| 76770 | A retroperitoneal ultrasound is a noninvasive procedure used to assess the body parts within the abdomen (i.e.Kidneys, urinary bladder, and aorta). This particular code is used when the ultrasound is… | 100 | $100 | $10K |
| 88112 | Selective cellular enhancement for cytopathology, such as the method of using a liquid–based slide preparation, uses a liquid–based medium to collect samples and preserve cells which can aid in… | 400 | $20 | $9.6K |
Showing 1–10 of 30
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 30 CPT/HCPCS codes.
View: State1 / 2
Full comparison — all codes billed, vs. state median
30 rows
| CPT/HCPCS Code | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|
| 88120 | 8 | 30 | 90 | $450 | $133.6K |
| 51792 | 7 | 20 | 110 | $230 | $23.2K |
| 99214 | 17,867 | 30,450 | 90 | $100 | $19K |
| 51729 | 51 | 80 | 30 | $330 | $16.8K |
| 51728 | 15 | 170 | 30 | $310 | $16K |
| 52275 | 2 | 10 | 20 | $500 | $14.5K |
| 99213 | 6,132 | 31,440 | 80 | $70 | $12.1K |
| 52281 | 30 | 50 | 20 | $300 | $11.5K |
| 88112 | 37 | 330 | 130 | $40 | $11.1K |
| 93975 | 35 | 330 | 30 | $190 | $11K |
Showing 1–10 of 30
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
4 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 88342 | The lab analyst applies an initial single antibody stain on a slide or slides prepared from a single patient specimen, such as tumor tissue. Then a qualified provider, typically a pathologist,… | 70 | $60 | $3.7K |
| 88373 | The lab analyst applies an additional in situ hybridization single probe stain on a slide or slides prepared from the same patient specimen as the initial probe stain, such as tumor tissue. The lab… | 60 | $30 | $1.9K |
| 88367 | The lab analyst applies an initial in situ hybridization single probe stain on a slide or slides prepared from a single patient specimen, such as tumor tissue. The lab analyst processes the slides… | 60 | $10 | $780 |
| 88112 | Selective cellular enhancement for cytopathology, such as the method of using a liquid–based slide preparation, uses a liquid–based medium to collect samples and preserve cells which can aid in… | 70 | $10 | $680 |
How this provider's Medicaid billing volume and revenue compare to other New York providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. New York median
4 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| 88342 | The lab analyst applies an initial single antibody stain on a slide or slides prepared from a single patient specimen, such as tumor tissue. Then a qualified provider, typically a pathologist,… | 267 | 340 | 510 | $50 | $80K |
| 88373 | The lab analyst applies an additional in situ hybridization single probe stain on a slide or slides prepared from the same patient specimen as the initial probe stain, such as tumor tissue. The lab… | 2 | 10 | 1,720 | $20 | $42.6K |
| 88112 | Selective cellular enhancement for cytopathology, such as the method of using a liquid–based slide preparation, uses a liquid–based medium to collect samples and preserve cells which can aid in… | 99 | 150 | 240 | $30 | $38.6K |
| 88367 | The lab analyst applies an initial in situ hybridization single probe stain on a slide or slides prepared from a single patient specimen, such as tumor tissue. The lab analyst processes the slides… | 3 | 10 | 70 | $20 | $19.1K |
Other providers in the same ZIP code as Himansh Khanna, ranked by combined Medicare and Medicaid revenue.
| Provider | State | Taxonomy | Medicare Revenue | Medicaid Revenue |
|---|---|---|---|---|
| Family Home Care Services Of Brooklyn & Queens, Inc. | NY | Home Health Agency | $0 | $158.5M |
| Novel Home Health Care Services Of New York Corp. | NY | Home Health Agency | $0 | $79.1M |
| New York And Presbyterian Hospital | NY | General Acute Care Hospital | $0 | $49.5M |
| Kings Physician Services, PC | NY | Diagnostic Radiology Physician | $0 | $47.3M |
| New York Dialysis Services, Inc. | NY | End-Stage Renal Disease (ESRD) Treatment Clinic/Center | $0 | $20M |
| Racquel Volkowitz | NY | Physician Assistant | $2M | $0 |
| Vinod Patel | NY | Interventional Cardiology Physician | $1.1M | $349.6K |
| Zev Lati | NY | Internal Medicine Physician | $854.1K | $82.1K |
| Shazia Amar | NY | Foot & Ankle Surgery Podiatrist | $144.6K | $775.5K |
| Robert Feig | NY | Ophthalmology Physician | $376.6K | $413.5K |
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.